Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Joseph Douglas Lyon, See Remarks of Corcept Therapeutics Inc, sold 10,000 shares of common stock on September 14, 2026.
Summary
- Option exercise/conversion: acquired 2,596 Common Stock at $11.35 ($29,465) on September 14, 2026; holds 8,279 after (Direct).
- Option exercise/conversion: acquired 7,404 Common Stock at $13.56 ($100,398) on September 14, 2026; holds 15,683 after (Direct).
- Open-market sale: disposed of 7,812 Common Stock at $113.32 ($885,261) on September 14, 2026; holds 7,871 after (Direct).
- Open-market sale: disposed of 2,188 Common Stock at $114.12 ($249,686) on September 14, 2026; holds 5,683 after (Direct).
- Option exercise/conversion: disposed of 2,596 Stock option (right to buy) on September 14, 2026 (Direct).
- Option exercise/conversion: disposed of 7,404 Stock option (right to buy) on September 14, 2026; holds 4,167 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,134,947 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Joseph Douglas Lyon — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Option exercise/conversion | Common Stock | 2,596 | $11 | $29.5K | 8,279 |
| 2026-09-14 | Option exercise/conversion | Common Stock | 7,404 | $14 | $100.4K | 15,683 |
| 2026-09-14 | Open-market sale | Common Stock | 7,812 | $113 | $885.3K | 7,871 |
| 2026-09-14 | Open-market sale | Common Stock | 2,188 | $114 | $249.7K | 5,683 |
| 2026-09-14 | Option exercise/conversion | Stock option (right to buy) | 2,596 | — | — | 0 |
| 2026-09-14 | Option exercise/conversion | Stock option (right to buy) | 7,404 | — | — | 4,167 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Option exercise/conversion (2,596 shares) |
| 2026-09-14 | Option exercise/conversion (7,404 shares) |
| 2026-09-14 | Open-market sale (7,812 shares) |
| 2026-09-14 | Open-market sale (2,188 shares) |
| 2026-09-14 | Option exercise/conversion (2,596 shares) |
| 2026-09-14 | Option exercise/conversion (7,404 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Joseph Douglas Lyon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.